HGGC is a leading equity investment organization that mainly focuses on leveraged buyout business transactions and the growth capital investments in the middle-market businesses. The firm has a unique and talented team of experts with many years of operational experience and a collective deal.
The company was designed to bring excellent practices of global corporations and private equity to develop the middle market enterprises which out-perform the current market. The company specializes in platform investments, recapitalizations, add-on acquisitions, growth equity, and corporate carve-outs.
HGGC seeks to invest in enterprise services, consumer products, industrial services, healthcare, financial services, infrastructure, and software. The company mainly invests in the country and also puts into consideration international opportunities.
HGGC Executive Appointments
The HGGC Company recently had six new hires across the operations, financial and investment functions. The six additions which come to the firm from the blue-chip commercial and enterprise brands will ensure that the organization has the much-needed bandwidth and talent to execute a successful investment strategy and foster portfolio value creation as it works on its growth trajectory.
The six additions include Colin Phinisey who is a seasoned investment and banking expert. He has many years of experience with a wide range of capital market and business transactions which include debt financings, mergers and acquisitions, and leveraged buyouts. Christopher Guinn is also among the six additions, and he joins the HGGC as an executive director.
Other additions include Zachary Adams, Patrick Malanga, William Spector and Hao Qin from Onex firm where he was an Associate. Hao Qin also served as an Investment Banking Analyst at the Goldman Sachs.
The company recently announced the acquisition of the RPX Corporation, which is a provider of the patent risks and discovery management solutions. Currently, there are no financial terms disclosed, however previous reports of the acquisition pegged the entire amount of the process at $ 10.5 per share.
The RPX marks the company’s second take-private deal after the acquisition of the Nutraceutical International Corporation a distributor and manufacturer of natural minerals, vitamins, personal care products, and supplements. These new acquisitions demonstrate an additional sourcing pool for the firm’s established partnership investment strategies.